✦ LIBER ✦

Effect of the selective MAO-A inhibitors brofaromine, clorgyline and moclobemide on human platelet MAO-B activity

✍ Scribed by C. H. Gleiter; E. Nilsson; B. Mühlbauer; K. H. Antonin; P. R. Bieck

Publisher: Springer
Year: 1992
Tongue: English
Weight: 277 KB
Volume: 89
Category: Article
ISSN: 1435-1463
DOI: 10.1007/bf01245359

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of oral moclobemide in

Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites

✍ F. -A. Wiesel; J. Raaflaub; R. Kettler 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 714 KB

Effect of the MAO-B inhibitor, MDL72974,

Effect of the MAO-B inhibitor, MDL72974, on superoxide dismutase activity and lipid peroxidation levels in the mouse brain

✍ C. Thiffault; R. Quirion; J. Poirier 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

MDL72974 is a member of a series of MAO-B inhibitors to be used as potential therapeutic agents in the treatment of Parkinson's and Alzheimer's diseases. However, we have recently observed a reduction in the density of tyrosine hydroxylase (TH)-positive neurons in the substantia nigra of mice treate

The effect of CV-4151, a selective inhib

The effect of CV-4151, a selective inhibitor of thromboxane synthetase, on prostanoid formation and platelet aggregation in humans

✍ Tsunehiko Kuzuya; Yoshihiro Kimura; Shiro Hoshida; Kazuhisa Kodama; Nobuto Nakam 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 585 KB

The pharmacokinetics and pharmacologic effects of a potent, selective inhibitor of thromboxane synthetase, CV-4151 [(E)-7-phenyl-7-(3-pyridyl)-6-heptenoic acid] on prostanoid formation and platelet aggregation were studied in 42 healthy male volunteers. The drug was well tolerated. After oral admini

Inhibitory effect of meloxicam, a select

Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers

✍ Bing Xin; Yoshihito Yokoyama; Tatsuhiko Shigeto; Masayuki Futagami; Hideki Mizun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

## Abstract ## BACKGROUND. It was recently reported that high expression of peroxisome proliferator‐activated receptor γ (PPARγ) and low expression of cyclooxygenase‐2 (COX‐2) might be involved in the inhibition of ovarian tumor progression and confirmed that PPARγ activation could suppress COX‐2